In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein–Barr virus–associated post-transplant lymphoproliferative disorder

Autor: Thieme, Constantin J., Schulz, Malissa, Wehler, Patrizia, Anft, Moritz, Amini, Leila, Blàzquez-Navarro, Arturo, Stervbo, Ulrik, Hecht, Jochen, Nienen, Mikalai, Stittrich, Anna-Barbara, Choi, Mira, Zgoura, Panagiota, Viebahn, Richard, Schmueck-Henneresse, Michael, Reinke, Petra, Westhoff, Timm H., Roch, Toralf, Babel, Nina
Zdroj: In Kidney International December 2022 102(6):1392-1408
Databáze: ScienceDirect